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New Suspect SARS Case Reported in Southern China
On January 8, 2004, the Chinese Ministry of Health (MOH) and the World Health Organization (WHO) reported a 
suspect case of severe acute respiratory syndrome (SARS) in a 20-year-old woman who works in a restaurant in 
Guangdong Province, China. A notice describing the new suspect case is provided below and is available on the 
WHO website at http://www.who.int/csr/don/2004_01_08/en/.
According to a Chinese MOH surveillance report and the WHO notice, the woman reported feeling discomfort on 
December 25 and had onset of fever on December 26. She was admitted to a hospital in Guangzhou city on 
December 31 and was transferred to an isolation room for treatment. On January 7, a panel of Chinese medical 
experts made a diagnosis of suspected SARS, and the patient was transferred to another hospital in Guangzhou 
city. She is reportedly in stable condition and has remained afebrile for the past 7 days. All 48 identified close 
contacts and 52 other contacts have shown no signs of illness to date. Additional epidemiologic investigations and 
laboratory studies are under way.
This is the second recent report of SARS in Guangdong Province. On January 5, the Chinese MOH and WHO 
announced that laboratory test results had confirmed evidence of SA RS coronavirus (SARS-CoV) in a 32-year-old 
man in Guangdong Province, China. He remains in good condition, has been discharged from the hospital, and all 
81 identified contacts are reported to be well. Chinese government authorities have initiated several measures to 
minimize contact between humans and animals thought to carry SA RS CoV, including the culling of masked palm 
civits and related wild-animal species. The culling is expected to be completed within the next few days.
No link has been established at present between the confirmed case and the new suspect SA RS case, and the 
source of exposure for both cases is unclear. A WHO team is traveling to Guangdong Province today to join 
Chinese MOH officials in conducting an expanded epidemiologic investigation of the confirmed case; activities will 
include searching for other human SARS cases and attempting to identify potential sources of animal-to-human 
transmission of SARS-CoV.
On a related matter, the Philippine Department of Health announced on January 7 that laboratory testing of a 
suspect SARS patient in Manila was negative for SARS-CoV, and the patient's illness has been reclassified as 
bacterial pneumonia. None of the patient's 46 contacts have shown signs of SARS-like illness. Additional 
information is available on the website of the WHO Western Region Office 
http://www.wpro.who.int/public/press_release/press_view.asp?id=323.
CDC remains in close communication with WHO about the newly identified suspect case in China and will provide 
additional information as it becomes available. The current U.S. guidelines and recommendations for SARS 
surveillance, evaluation, and reporting in the absence of SARS-CoV transmission still apply. Surveillance efforts 
in the current setting should aim to identify patients who require hospitalization for radiographically confirmed
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pneumonia or acute respiratory distress syndrome without identifiable etiology AND who have one of the following 
risk factors in the 10 days before the onset of illness:
• Travel to mainland China, Hong Kong, or Taiwan, or close contact with an ill person with a history of recent
travel to one of these areas, OR
• Employment in an occupation associated with a risk for SARS-CoV exposure (e.g., healthcare worker with
direct patient contact; worker in a laboratory that contains live SARS-CoV), OR
• Part of a cluster of cases of atypical pneumonia without an alternative diagnosis
Infection control practitioners and other healthcare personnel should also be alert for clusters of pneumonia 
among two or more healthcare workers who work in the same facility.
For more information about current U.S. SA RS control guidelines, see the CDC document, “ In the Absence of 
SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and 
Reporting” at http://www.cdc.gov/ncidod/sars/absenceofsars.htm. The document is part of CDC's draft Public 
Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome 
(SARS) http://www.cdc.gov/ncidod/sars/sarsprepplan.htm.
Announcement of suspected SARS case in southern China; Investigation of source of infection for confirmed case 
begins tomorrow
8 January 2004
Health authorities in China have today announced a suspected case of SARS in the southern province of 
Guangdong. The patient, who has been treated under isolation since 31 December, is a 20-year-old woman from 
Henan Province who works at a restaurant in Guangzhou, the provincial capital city.
The patient felt unwell on 25 December, developed a fever the following day, and sought medical treatment on 31 
December. In line with diagnostic and management protocols issued by the Chinese Ministry of Health, she was 
immediately placed in isolation. She was diagnosed as a suspected case following review by a panel of Chinese 
SARS experts. Epidemiological investigations and laboratory tests are under way. The patient has been afebrile 
for the past seven days and is said to be in stable condition.
Altogether 100 contacts have been traced and placed under medical observation. At present, no signs or 
symptoms suggestive of SA RS have developed in any of these contacts.
The announcement follows Monday's laboratory confirmation of SA RS in a 32-year-old male resident of 
Guangzhou. The man has fully recovered and has been discharged from hospital. All close contacts of the 
patient, including health care workers, have remained in good health throughout the observation period, which 
has now ended.
At present, no epidemiological evidence has linked the confirmed case with the suspected case. The possible 
source of exposure in both cases is under investigation.
Symptoms of SARS mimic those of several other respiratory diseases, including many that are more frequently 
seen during the winter months. Some of these diseases may also give rise to atypical pneumonia. It is likely that 
numerous other suspected cases will be reported over the coming weeks.
All currently available SARS diagnostic tests have shortcomings. In view of these limitations, WHO recommends 
that specimens taken from suspected SA RS cases for laboratory analysis include nasopharyngeal aspirates and 
stool samples as well as serum. Each specimen should be divided into samples at the bedside, rather than in a 
laboratory where the risk of contamination is heightened. When positive or inconclusive results are obtained, one 
of the samples should be sent for independent testing at a WHO-designated SA RS reference laboratory.
Investigative team arrives in Guangdong
A joint team of WHO and Chinese experts has arrived today in Guangdong to investigate possible sources of 
infection for the confirmed SARS case. Over the coming days, parallel investigations will look at possible human- 
to-human, animal-to-human, and environmental sources of transmission. Further information about the team is 
provided on the web site of the WHO Regional Office for the Western Pacific.
Animal experts will also examine conditions surrounding the culling of masked palm civets and other wildlife 
species, and make recommendations for research that could shed light on the origins of the SA RS coronavirus.
The SA RS virus, which first emerged in Guangdong in mid-November 2002, is thought to have jumped to humans 
from some unidentified animal or environmental reservoir. Further research is urgently needed to determine 
sources of human exposure, including the possible involvement of specific animal species.
An investigation by a previous joint team of experts, conducted in Guangdong from 20 December to 2 January 
2004, found a very high level of awareness of the symptoms of SARS among health care workers and 
pharmacists, and a very high level of preparedness to introduce appropriate public health measures. Good levels 
of infection control were in place at all four facilities where the confirmed case was examined or treated. Local and 
national authorities were rapidly alerted, and the tracing of 81 contacts was completed within 2 days.
Source: WHO Geneva http://www.who.int/csr/don/2004_01_08/en/
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
DEPARTMENT OF HEALTH AND HUMAN SERV IC ES
